Drug therapy for portal hypertension.
Lebrec
D
D
Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481 and Service d'Hépatologie, Hôpital Beaujon, Clichy, France. lebrec@bichat.inserm.fr
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005773:Gastroscopy; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000188:drug therapy*; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D012106:Research; D013004:Somatostatin / Q000627:therapeutic use; D000077585:Terlipressin; D014667:Vasopressins / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014667:Vasopressins; D008236:Lypressin; D013004:Somatostatin; D000077585:Terlipressin